Busulfan
An alkylating agent used to condition patients for bone marrow transplantation by destroying the existing bone marrow and suppressing the immune system to allow engraftment. It is also used in the treatment of chronic myelogenous leukemia. Major side effects include severe bone marrow suppression, pulmonary toxicity, and risk of secondary cancers.
Молекулярная масса
246,3000 g/mol
LogP
-0,50
TPSA
104,00 Ų
Правило пяти Липинского
Соответствует
Терапевтические области
Механизм действия
Forms covalent bonds with DNA bases, creating cross-links and strand breaks that prevent DNA replication and transcription. This triggers apoptosis in rapidly dividing cells, particularly cancer cells.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Forms covalent bonds with DNA bases, creating cross-links and strand breaks that prevent DNA replication and transcription. This triggers apoptosis in rapidly dividing cells, particularly cancer cells.
2D Структура
Cite this structure
Embed this structure
SMILES
CS(=O)(=O)OCCCCOS(C)(=O)=O
InChI
InChI=1S/C6H14O6S2/c1-13(7,8)11-5-3-4-6-12-14(2,9)10/h3-6H2,1-2H3
Molecular Formula
C6H14O6S2
HBD / HBA
- / 6
Вращаемые Связи
7
Тяжёлые Атомы
14
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Часто задаваемые вопросы
An alkylating agent used to condition patients for bone marrow transplantation by destroying the existing bone marrow and suppressing the immune system to allow engraftment. It is also used in the treatment of chronic myelogenous leukemia. Major side effects include severe bone marrow suppression, pulmonary toxicity, and risk of secondary cancers.
Forms covalent bonds with DNA bases, creating cross-links and strand breaks that prevent DNA replication and transcription. This triggers apoptosis in rapidly dividing cells, particularly cancer cells.
Yes, Busulfan is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL820. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 2478. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.
Медицинский отказ от ответственности
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="busulfan"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/busulfan/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/busulfan/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/busulfan/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="busulfan"></drugfyi-drug>